[Organization and management of acute complete atrioventricular block: Results from a Multicenter National Survey].

Organisation et gestion aiguë du bloc atrioventriculaire complet : résultats d’une enquête multicentrique nationale.

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 29 10 2020
accepted: 28 01 2021
pubmed: 2 3 2021
medline: 27 10 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

Complete atrioventricular block (AVB3) may be an urgent potentially lifethreatening situation. Our objective was to describe the routine management of AVB 3, with emphasis on the organizational aspects. From September 2019 to November 2019, a prospective national survey including 28 questions was electronically sent to 100 physicians (Google Form). The answers were collected from 93 physicians (response rate 93%). Permanent pacemaker implantation during weekends and nights (after 8PM) is possible for 49% of the operators (<5 times a year), for 15% (>5 times a year), impossible for 36% of the operators. For AVB3 nonresponsive to isoproterenol occurring during the night, a temporary pacing lead (TPL) is implanted by: the on-site medical staff on-duty (27%), the on-call interventional cardiologist (21%), the on-call electrophysiologist (19%), a permanent pacemaker is implanted by the electrophysiologist (12%), the strategy is not standardized (15%). An externalized active fixation lead (AFL) for AVB3 has already been implanted by 50% of the operators. 80 (86%) have already observed a dislocation of the TPL, a cardiac perforation already occurred in 57 (61%), a groin hematoma in 35 (38%), and this technique was proscribed for 4% of the operators. Our survey shows important disparities in terms of management of AVB3 among the different centers. An externalized AFL with a reusable generator was used by half of the centers.

Sections du résumé

BACKGROUND BACKGROUND
Complete atrioventricular block (AVB3) may be an urgent potentially lifethreatening situation. Our objective was to describe the routine management of AVB 3, with emphasis on the organizational aspects.
METHODS METHODS
From September 2019 to November 2019, a prospective national survey including 28 questions was electronically sent to 100 physicians (Google Form).
RESULTS RESULTS
The answers were collected from 93 physicians (response rate 93%). Permanent pacemaker implantation during weekends and nights (after 8PM) is possible for 49% of the operators (<5 times a year), for 15% (>5 times a year), impossible for 36% of the operators. For AVB3 nonresponsive to isoproterenol occurring during the night, a temporary pacing lead (TPL) is implanted by: the on-site medical staff on-duty (27%), the on-call interventional cardiologist (21%), the on-call electrophysiologist (19%), a permanent pacemaker is implanted by the electrophysiologist (12%), the strategy is not standardized (15%). An externalized active fixation lead (AFL) for AVB3 has already been implanted by 50% of the operators. 80 (86%) have already observed a dislocation of the TPL, a cardiac perforation already occurred in 57 (61%), a groin hematoma in 35 (38%), and this technique was proscribed for 4% of the operators.
CONCLUSION CONCLUSIONS
Our survey shows important disparities in terms of management of AVB3 among the different centers. An externalized AFL with a reusable generator was used by half of the centers.

Identifiants

pubmed: 33642047
pii: S0003-3928(21)00024-X
doi: 10.1016/j.ancard.2021.01.007
pii:
doi:

Substances chimiques

Cardiotonic Agents 0
Isoproterenol L628TT009W

Types de publication

Journal Article Multicenter Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

68-74

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

S-S Bun (SS)

Department of Cardiology, Pasteur University Hospital, 30, avenue de la voie Romaine, Nice, France. Electronic address: soksithikun@hotmail.com.

J Taïeb (J)

Centre hospitalier du pays d'Aix, Aix-en-Provence, France.

D Scarlatti (D)

Department of Cardiology, Pasteur University Hospital, 30, avenue de la voie Romaine, Nice, France.

F Squara (F)

Department of Cardiology, Pasteur University Hospital, 30, avenue de la voie Romaine, Nice, France.

P Taghji (P)

Hôpital La Timone, Marseille, France.

A Errahmouni (A)

Dupuytren University Hospital, Limoges, France.

K Hasni (K)

Centre Hospitalier Princesse Grace, Monaco (Principauté).

B Enache (B)

Centre Hospitalier Princesse Grace, Monaco (Principauté).

W Amara (W)

Groupement Hospitalier le Raincy-Montfermeil, Montfermeil, France.

J-C Deharo (JC)

Hôpital La Timone, Marseille, France.

E Ferrari (E)

Department of Cardiology, Pasteur University Hospital, 30, avenue de la voie Romaine, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH